📅Offer Date: 18 Jun 2026 – 22 Jun 2026
Data sourced from BSE & NSE · Last updated
Avience Biomedicals Limited IPO was subscribed 385.33x in total when bidding closed on 22 Jun 2026, with 196.77x in the QIB category, 597.62x in NII, 401.21x in retail. The issue ran from 18 Jun 2026 to 22 Jun 2026 at a price band of ₹196.00–₹208.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (401.21x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 2,73,600 | 5,38,36,272 | 196.77x |
| NIIs | 2,07,000 | 12,37,07,340 | 597.62x |
| SNIIs (<10L) | 69,000 | 3,11,41,080 | 451.32x |
| BNIIs (>10L) | 1,38,000 | 9,25,66,260 | 670.77x |
| Retail | 4,81,200 | 19,30,62,252 | 401.21x |
| Total | 9,61,800 | 37,06,10,394 | 385.33x |
| QIB / NII | 2,73,600 | 0 | 0.00x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 5.69 | 1119.79 | 196.77x |
| NIIs | 4.31 | 2573.11 | 597.62x |
| Retail | 10.01 | 4015.69 | 401.21x |
| QIB / NII | 5.69 | — | 0.00x |
| Total | 25.70 | 7708.60 | 385.33x |
Values derived from share count × issue price (₹208.00)
Because Avience Biomedicals Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
NSE SME listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.